| ||
DEA: Throwing out unused prescriptions can stop drug abuse Boston Globe By Globe Staff Bay State residents on Saturday will be able to throw out old prescription drugs as part of a national effort to weaken the black market for unused medications, and to reduce first time drug use by teens. The effort is being led by the ... See all stories on this topic » | ||
FDA Opens Hearings on Genetically Modified Salmon Wall Street Journal AP WASHINGTON—Federal food regulators pondered Monday whether to say, for the first time, that it is permissible to market a genetically engineered animal as safe for people to eat. The Food and Drug Administration is holding two days of hearings on a ... See all stories on this topic » | ||
Boston Scientific to buy privately held Asthmatx The Associated Press NATICK, Mass. — Boston Scientific will buy privately held Asthmatx Inc. in a deal that could be worth more than $440 million, the medical device maker said Monday. Boston Scientific, which is based in Natick, said it will pay $193.5 million in cash up ... See all stories on this topic » | ||
Increase in Seizures Seen in Kids With H1N1 Flu BusinessWeek MONDAY, Sept. 20 (HealthDay News) -- Children made ill by the 2009 pandemic H1N1 swine flu virus suffered more seizures and other nervous system problems than those with seasonal flu, a new report reveals. In the study, published in the September issue ... See all stories on this topic » | ||
Wisconsin D.A. in texting scandal retains attorney, on medical leave CNN By Antoinette Campbell (CNN) -- The Wisconsin prosecutor at the center of a texting scandal has retained an attorney, and is on medical leave, according to the Calumet County District Attorney's office. District Attorney Ken Kratz apologized Friday for ... See all stories on this topic » | ||
Investigational Drug Dapagliflozin For Diabetes Meets Study Goals After 24 ... Medical News Today Dapagliflozin when added to existing glimepiride (sulphonylurea) therapy significantly reduced HbA1C (glycosylated hemoglobin) in adults with Type 2 Diabetes, compared to patients taking glimepiride plus a placebo, a 24-week Phase 3 Study revealed. ... See all stories on this topic » | ||
| ||
Johnson & Johnson's troubled times CNN By Parija Kavilanz, senior writerSeptember 20, 2010: 10:13 AM ET NEW YORK (CNNMoney.com) -- Criminal investigations, "phantom" recalls and executive oustings are exposing a dark side of Johnson & Johnson, once considered a pillar of American industry. ... See all stories on this topic » |
This as-it-happens Google Alert is brought to you by Google.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment